Safety and efficacy of combination vaccines.
作者信息
Elliman David, Bedford Helen
出版信息
BMJ. 2003 May 10;326(7397):995-6. doi: 10.1136/bmj.326.7397.995.
Abstract
摘要
相似文献
1
Safety and efficacy of combination vaccines.
BMJ. 2003 May 10;326(7397):995-6. doi: 10.1136/bmj.326.7397.995.
2
Efficacy, safety, and formulation issues of the combined vaccines.
Expert Rev Vaccines. 2020 Oct;19(10):949-958. doi: 10.1080/14760584.2020.1843434. Epub 2020 Nov 16.
3
Combination vaccines: postlicensure safety evaluation.
Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S327-33. doi: 10.1086/322569.
4
Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.
Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):138-47.
5
Postmarketing surveillance of rabies vaccines for dogs to evaluate safety and efficacy.
J Am Vet Med Assoc. 2008 Apr 1;232(7):1000-2. doi: 10.2460/javma.232.7.1000.
6
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.
7
Perspectives on the design and analysis of prelicensure trials: bridging the gap to postlicensure studies.
Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S323-6. doi: 10.1086/322568.
8
Postmarketing surveillance study of a non-chlorofluorocarbon inhaler Postmarketing surveillance studies remain unethical.
BMJ. 1999 Mar 20;318(7186):810-11.
9
Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).
Expert Rev Vaccines. 2009 Jun;8(6):663-78. doi: 10.1586/erv.09.32.
10
Postmarketing surveillance study of a non-chlorofluorocarbon inhaler. Such studies initiated by manufacturer are designed to promote product.
BMJ. 1999 Mar 20;318(7186):810, author reply 810-11.
引用本文的文献
1
The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024.
Hum Vaccin Immunother. 2025 Dec;21(1):2525603. doi: 10.1080/21645515.2025.2525603. Epub 2025 Jul 11.
2
Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections.
Vaccines (Basel). 2025 Mar 21;13(4):335. doi: 10.3390/vaccines13040335.
3
Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2333098. doi: 10.1080/21645515.2024.2333098. Epub 2024 Apr 15.
4
Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China.
Int J Environ Res Public Health. 2022 Nov 23;19(23):15557. doi: 10.3390/ijerph192315557.
5
COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy.
Pharmaceuticals (Basel). 2022 Mar 8;15(3):322. doi: 10.3390/ph15030322.
6
Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards.
Osong Public Health Res Perspect. 2018 Oct;9(5):278-282. doi: 10.24171/j.phrp.2018.9.5.10.
本文引用的文献
1
Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.
Commun Dis Public Health. 2003 Apr;6(1):55-8.
2
Bacterial infections, immune overload, and MMR vaccine. Measles, mumps, and rubella.
Arch Dis Child. 2003 Mar;88(3):222-3. doi: 10.1136/adc.88.3.222.
3
MMR vaccine: review of benefits and risks.
J Infect. 2002 Jan;44(1):1-6. doi: 10.1053/jinf.2001.0930.
4
Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?
Pediatrics. 2002 Jan;109(1):124-9. doi: 10.1542/peds.109.1.124.
5
Combination vaccines: defining and addressing current safety concerns.
Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S312-8. doi: 10.1086/322567.
6
Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
J Pediatr. 2000 Sep;137(3):304-12. doi: 10.1067/mpd.2000.107796.
7
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster.
Vaccine. 2000 Apr 28;18(21):2295-306. doi: 10.1016/s0264-410x(99)00539-3.
8
Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.
Infect Immun. 1998 May;66(5):2093-8. doi: 10.1128/IAI.66.5.2093-2098.1998.
9
Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.
Lancet. 1998 Feb 28;351(9103):637-41. doi: 10.1016/s0140-6736(97)11096-0.
10
Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
Pediatr Infect Dis J. 1997 Sep;16(9):863-70. doi: 10.1097/00006454-199709000-00009.
Zotero 插件